GBA1 and Parkinson disease: This lack of a clear data on accumulation of GBA substrates in some PD-GBA models and samples from PD patients carrying heterozygous GBA mutations might suggest that residual GCase activity may be enough to avoid the massive accumulation of GlcCer and GlcSph and raises concerns about the role of these sphingolipids in the pathogenesis of PD.